26 January 2023
We are pleased to announce that we are recruiting a new clinical lead for our HQIP-commissioned National Early Inflammatory Arthritis Audit (NEIAA), as our current clinical lead, Jo Ledingham, takes up the role of BSR President. This high-profile role provides a unique opportunity for someone with a clinical background who has a passion for clinical audit and quality improvement, at a national level.
In October 2022, BSR secured a further 3-year contract to continue managing the audit which will evolve through its new contract to include other rare immune-mediated inflammatory diseases. With these developments on the horizon, it is an exciting time to be a part of the audit, with so much impact to be had on patient care and improving pathways. The successful candidate will work alongside a team of impassioned colleagues to increase participation, develop quality improvement initiatives, and raise the profile of the audit.
Jo Ledingham, who has been the clinical lead for NEIAA since the start had the following to say about her experience:
“This has been a hugely stimulating piece of work, involving close engagement with clinical colleagues all over England and Wales. One of the most gratifying aspects of the role has been the clear positive impact on patient care achieved. It has also been wonderful to see how well the rheumatology community has engaged with the audit and to see the raised profile of rheumatology services as a consequence of the audit”
To find out more about the position please click the links below:
- job description
- advert
Closing date to submit applications: Midnight 12 February 2023
We would also encourage you to reach out to Jo or the audit team with any queries you may have at: audit@rheumatology.org.uk.